EDITORIAL SECTION

Articles

The Future of Oncology Clinical Trials: Adaptive, Biomarker-Led, and AI-Enabled

Oncology now absorbs close to a third of the industrys active development pipeline and a comparable share of its research budget It also carries the worst odds in medicine A molecule entering firstinhuman cancer studies has historically had a midsingledigit probability of reaching approval against roughly double that across other therapy areas For a European chief executive allocating capital acro...

Leveraging Blockchain for Drug Traceability and Security in Europe

The area of interest in the pharmaceutical products in the past couple of years has been in the area of traceability and security Recently there has been an increase in fake drugs as well as advanced supply chain management making it difficult to tell the actual quality of the manufactured drugs

COA and Lot Traceability: The Backbone of Reproducible Pharma Research

A pharmaceutical experiment can be repeated with the same protocol instrument settings and analyst yet still produce a different result The obvious suspects are usually the method or the equipment Sometimes the less visible variable is the material itself

Revolutionizing Pharma Supply Chains: Innovation – A Key Approach towards Efficiency and Compliance

Imagine if a pharmaceutical supply chain could add value to its operations by using advanced analytics and predictive maintenance With these new developments businesses can reduce equipment downtimes

Navigating the Pharma Market: Strategies for Successful Pharmaceutical Sales

Navigating the pharmaceutical market requires a blend of strategic planning industry knowledge and effective communication skills In this guide well explore key strategies for successful pharmaceutical sales in a way thats easy to understand

Personalized Medicine and Longevity: Advancing the Frontier

The world is experiencing a profound demographic shift with population aging impacting healthcare economies and human rights The United Nations projects that by the number of people aged and over will double to billion comprising one in six people worldwide United Nations OHCHR By older adults will likely outnumber children necessitating a rethink of health aging and longevity Hartmann Young

Techno Trends

Alume Biosciences Secures FDA Breakthrough Therapy Designation for Bevonescein

Alume Biosciences has received Breakthrough Therapy Designation BTD from the US Food and Drug Administration FDA for bevonescein an investigational fluorescent drug being developed to support realtime nerve visualisation during head and neck surgery in adults Bevonescein is an intravenous fluorescent peptidedye conjugate that binds to nerve tissue

Projects

SK pharmteco Plans More Than US$200 Million Investment in Small Molecule and Peptide Manufacturing

SK pharmteco is planning a fiveyear investment of more than US million to expand and modernise its pharmaceutical development and manufacturing operations in the United States The programme will strengthen capabilities for small molecules and peptides while supporting a more

Research Insights

One-month physicochemical stability study of idarubicin prepared in polyolefin-type bags for the treatment of hematological diseases

Idarubicine is a mainstay of the treatment strategy for hematological cancer The literature lacks stability data that comply with current preparation practices and recommendations for conducting stability studies

whitepaper

Post-Translational Modifications in Drug Discovery: From Molecular Regulation to Clinical Impact

For decades the central dogma of molecular biology has anchored our understanding of cellular function DNA to RNA to protein But this linear view is incomplete A growing body of evidence shows that much of biologys